Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haupt

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsC Bokemeyer, O Köhrmann, J Tischler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 5, 2008
Variation in the FTO gene influences food intake but not energy expenditureA Haupt, C Thamer, H Staiger, et al.
Diabetes, Obesity & Metabolism|October 28, 2010
Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et alB Gallwitz, A Haupt, P Kraus, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 6, 2018
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programmeK Cusi, N Sattar, L-E García-Pérez, et al.
The Pharmacogenomics Journal|November 22, 2017
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglisproS Pillai, S Duvvuru, P Bhatnagar, et al.
Diabetologia|February 12, 2008
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversionK Kirchhoff, F Machicao, A Haupt, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential actionS J Jacober, M J Prince, J M Beals, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|April 1, 1996
[Determining the effectiveness of percutaneous cava filters: experimental studies]J Neuerburg, A Haupt-Pichler, F J Katterbach, et al.
Diabetologia|January 28, 2009
The risk allele load accelerates the age-dependent decline in beta cell functionA Haupt, H Staiger, S A Schäfer, et al.
Population Today|May 1, 1986
The invisible hand in San FranciscoJ Adams, L Bouvier, C Davis, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsC Bokemeyer, O Köhrmann, J Tischler, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|December 5, 2008
Variation in the FTO gene influences food intake but not energy expenditureA Haupt, C Thamer, H Staiger, et al.
Diabetes, Obesity & Metabolism|October 28, 2010
Changes in body composition after 9 months of treatment with exenatide twice daily versus glimepiride: comment letter on Jendle et alB Gallwitz, A Haupt, P Kraus, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 6, 2018
Dulaglutide decreases plasma aminotransferases in people with Type 2 diabetes in a pattern consistent with liver fat reduction: a post hoc analysis of the AWARD programmeK Cusi, N Sattar, L-E García-Pérez, et al.
The Pharmacogenomics Journal|November 22, 2017
The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglisproS Pillai, S Duvvuru, P Bhatnagar, et al.
Diabetologia|February 12, 2008
Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversionK Kirchhoff, F Machicao, A Haupt, et al.
Diabetes, Obesity & Metabolism|October 11, 2016
Basal insulin peglispro: Overview of a novel long-acting insulin with reduced peripheral effect resulting in a hepato-preferential actionS J Jacober, M J Prince, J M Beals, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|April 1, 1996
[Determining the effectiveness of percutaneous cava filters: experimental studies]J Neuerburg, A Haupt-Pichler, F J Katterbach, et al.
Diabetologia|January 28, 2009
The risk allele load accelerates the age-dependent decline in beta cell functionA Haupt, H Staiger, S A Schäfer, et al.
Population Today|May 1, 1986
The invisible hand in San FranciscoJ Adams, L Bouvier, C Davis, et al.
Pageof 9